254 related articles for article (PubMed ID: 16080096)
1. Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring?
Imhof A; Ledergerber B; Günthard HF; Haupts S; Weber R;
Clin Infect Dis; 2005 Sep; 41(5):721-8. PubMed ID: 16080096
[TBL] [Abstract][Full Text] [Related]
2. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
Bolhaar MG; Karstaedt AS
Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.
Manosuthi W; Prasithsirikul W; Chumpathat N; Suntisuklappon B; Athichathanabadi C; Chimsuntorn S; Sungkanuparph S
Int J Infect Dis; 2008 Nov; 12(6):582-6. PubMed ID: 18337140
[TBL] [Abstract][Full Text] [Related]
4. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment.
Noguera A; Fortuny C; Sanchez E; Artuch R; Vilaseca MA; Muñoz-Almagro C; Pou J; Jiménez R
Pediatr Infect Dis J; 2003 Sep; 22(9):778-82. PubMed ID: 14506367
[TBL] [Abstract][Full Text] [Related]
5. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
Dragovic G; Jevtovic D
Biomed Pharmacother; 2012 Jun; 66(4):308-11. PubMed ID: 22658063
[TBL] [Abstract][Full Text] [Related]
6. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
[TBL] [Abstract][Full Text] [Related]
7. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
[TBL] [Abstract][Full Text] [Related]
8. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
Calza L; Manfredi R; Chiodo F
Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
[TBL] [Abstract][Full Text] [Related]
10. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
[TBL] [Abstract][Full Text] [Related]
11. Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients.
Marceau G; Sapin V; Jacomet C; Ughetto S; Cormerais L; Regagnon C; Dastugue B; Peigue-Lafeuille H; Beytout J; Laurichesse H
Clin Chem; 2003 Jul; 49(7):1154-62. PubMed ID: 12816913
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the effect of Stalanev (Stavudine, Lamivudine and Nevirapine) treatment on plasma lactate levels in adults attending Beatrice Road and Wilkins Infectious Diseases Hospital Opportunistic Infections Clinics in Harare, Zimbabwe.
Malunga G; Mujaji WB; Musarurwa C; Nyamayaro T
Cent Afr J Med; 2012; 58(5-6):22-5. PubMed ID: 26255331
[TBL] [Abstract][Full Text] [Related]
13. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Accutrend lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting.
Pérez EH; Dawood H; Chetty U; Esterhuizen TM; Bizaare M
Int J Infect Dis; 2008 Sep; 12(5):553-6. PubMed ID: 18511322
[TBL] [Abstract][Full Text] [Related]
15. Lactic acidosis associated with stavudine administration: a report of five cases.
Mokrzycki MH; Harris C; May H; Laut J; Palmisano J
Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755
[TBL] [Abstract][Full Text] [Related]
16. Lactic acidemia in infection with human immunodeficiency virus.
Carr A
Clin Infect Dis; 2003 Apr; 36(Suppl 2):S96-S100. PubMed ID: 12652378
[TBL] [Abstract][Full Text] [Related]
17. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study.
Osler M; Stead D; Rebe K; Meintjes G; Boulle A
HIV Med; 2010 Feb; 11(2):121-9. PubMed ID: 19702629
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis.
Lonergan JT; Barber RE; Mathews WC
AIDS; 2003 Nov; 17(17):2495-9. PubMed ID: 14600521
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
